X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Ieva M. Augstums

Ieva M. Augstums Ieva (YEH-vuh), Deputy Vice President of Public Affairs, joined PhRMA in 2014 and now oversees all branding and paid advertising, including PhRMA’s national multi-year GOBOLDLY campaign. She reported on the 2008 financial crisis and other financial market news during ten years as a journalist at the Dallas Morning News and the Associated Press, then directed national campaigns at a Washington-based strategic communications and brand consulting firm. A native Nebraskan, Ieva is a proud mother of two, dreams of opening a paperie and never passes up an opportunity to lace up for a rave run.

Recent Posts

The Partnership for Prescription Assistance: A history of caring

By Ieva M. Augstums  |    November 4, 2015
America is a country of problem solvers, innovators and dreamers. In April 2005, professionals on the front lines of health care at America’s biopharmaceutical research companies, created the...   Read More

Personalized Medicine: The next health frontier

By Ieva M. Augstums  |    October 23, 2015
One of PhRMA’s most important roles is serving as a convener. And earlier this week we joined with The Hill to convene two terrific discussions around personalized – or precision – medicine. We do...   Read More

Sharing a Story of Hope

By Ieva M. Augstums  |    October 21, 2015
All of us – patients, survivors and loved ones – face challenges from the moment of a disease diagnosis through treatment. And those challenges are personal. Ten years ago, there was no such thing...   Read More

PhRMA Honors Research & Hope Award Recipients

By Ieva M. Augstums  |    September 11, 2015
Imagine a world without cancer. Earlier this week, a group of trailblazers in the oncology community gathered to reflect on efforts to help make this dream a reality. PhRMA was pleased to host the   Read More

From Hope to Cures: The Value of Biopharmaceutical Innovation

By Ieva M. Augstums  |    August 20, 2015
Biopharmaceutical innovation means more than helping patients lead longer, healthier, more productive lives. Through the continued development of new treatments and cures, each discovery...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates